Ieq Capital LLC lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 88.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 67,200 shares of the medical equipment provider’s stock after purchasing an additional 31,566 shares during the period. Ieq Capital LLC’s holdings in Intuitive Surgical were worth $27,326,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Bank of New York Mellon Corp purchased a new stake in shares of Intuitive Surgical during the second quarter worth about $1,335,753,000. Arrowstreet Capital Limited Partnership increased its holdings in Intuitive Surgical by 95.3% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after purchasing an additional 1,027,475 shares during the period. Assenagon Asset Management S.A. increased its holdings in Intuitive Surgical by 55.8% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider’s stock valued at $633,505,000 after purchasing an additional 558,099 shares during the period. Mirae Asset Global Investments Co. Ltd. bought a new position in Intuitive Surgical during the 3rd quarter valued at approximately $136,743,000. Finally, Voya Investment Management LLC raised its position in Intuitive Surgical by 97.2% during the 3rd quarter. Voya Investment Management LLC now owns 491,914 shares of the medical equipment provider’s stock valued at $200,028,000 after purchasing an additional 242,468 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Insider Buying and Selling at Intuitive Surgical
In other news, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $458.15, for a total transaction of $183,260.00. Following the completion of the transaction, the executive vice president directly owned 6,236 shares in the company, valued at approximately $2,857,023.40. This trade represents a 6.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 1,078 shares of Intuitive Surgical stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total transaction of $478,416.40. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 39,317 shares of company stock valued at $17,720,016 over the last three months. 0.60% of the stock is currently owned by corporate insiders.
Intuitive Surgical Trading Down 3.3%
Shares of ISRG stock opened at $407.24 on Friday. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The stock has a market cap of $141.17 billion, a PE ratio of 49.24, a price-to-earnings-growth ratio of 2.90 and a beta of 1.45. The company’s fifty day moving average price is $422.91 and its 200-day moving average price is $428.31.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.35. The company had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. Intuitive Surgical’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same period last year, the business earned $2.40 EPS. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.
Latest Intuitive Surgical News
Here’s some of the latest news about ISRG:
- Positive Sentiment: Industry research highlights accelerating use of surgical robotics and growing da Vinci procedure volumes, including in gynecology. Intuitive is viewed as a leading platform provider, supporting its long-term growth outlook. Why Intuitive Surgical is at the center of the robotics boom
- Positive Sentiment: BTIG raised its price target to $513 from $454 and maintained a Buy rating, signaling increased analyst confidence in potential upside. BTIG analyst rating
- Neutral Sentiment: Coverage says ISRG was down 1.7% since its earnings report about a month ago and points investors to upcoming earnings estimates for clues on a possible rebound, without providing a specific estimate change. ISRG performance since earnings
Analysts Set New Price Targets
Several equities research analysts have weighed in on ISRG shares. Sanford C. Bernstein reiterated an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Royal Bank Of Canada reduced their target price on Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 21st. Raymond James Financial restated an “outperform” rating and set a $480.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 21st. BTIG Research raised their price target on Intuitive Surgical from $454.00 to $513.00 and gave the stock a “buy” rating in a research note on Wednesday. Finally, BNP Paribas Exane upgraded shares of Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $495.90.
Read Our Latest Stock Analysis on ISRG
Intuitive Surgical Company Profile
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
